Enanta Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US29251M1062

Introduction

This page provides a comprehensive analysis of the known insider trading history of Gardiner Nathaniel S.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Gardiner Nathaniel S. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ENTA / Enanta Pharmaceuticals, Inc. Chief Legal Officer 75,688
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Gardiner Nathaniel S.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ENTA / Enanta Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ENTA / Enanta Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2016-05-11 ENTA Gardiner Nathaniel S. 500 24.4450 500 24.4450 12,222 240 36.0500 5,803 47.48
2015-02-17 ENTA Gardiner Nathaniel S. 600 33.4700 600 33.4700 20,082
2015-02-17 ENTA Gardiner Nathaniel S. 400 33.1000 400 33.1000 13,240
2015-02-13 ENTA Gardiner Nathaniel S. 400 33.0000 400 33.0000 13,200

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENTA / Enanta Pharmaceuticals, Inc. Insider Trades
Insider Sales ENTA / Enanta Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ENTA / Enanta Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-12-05 ENTA Gardiner Nathaniel S. 2,412 9.6300 2,412 9.6300 23,228 366 8.0100 -3,907 -16.82

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENTA / Enanta Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Gardiner Nathaniel S. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-02-27 2024-02-26 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 5,187 75,688 7.36 8.99 46,631 680,435
2024-02-14 2024-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -973 70,501 -1.36 12.41 -12,075 874,917
2024-02-14 2024-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 3,320 71,474 4.87
2023-12-06 2023-12-05 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
S - Sale -2,412 68,154 -3.42 9.63 -23,228 656,323
2023-12-05 2023-12-01 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -1,595 70,566 -2.21 9.49 -15,137 669,671
2023-04-19 2023-04-18 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 6,667 79,980 9.09 30.00 200,010 2,399,400
2023-02-15 2023-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -6,735 73,313 -8.41 52.77 -355,406 3,868,727
2023-02-15 2023-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 11,747 80,048 17.20
2023-02-15 2023-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 9,250 68,301 15.66
2022-12-05 2022-12-01 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -1,055 59,051 -1.76 44.33 -46,768 2,617,731
2022-11-28 2022-11-23 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 21,000 60,106 53.70
2022-02-15 2022-02-14 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -957 46,239 -2.03 62.49 -59,803 2,889,475
2022-02-15 2022-02-14 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 2,419 47,196 5.40
2022-02-15 2022-02-14 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 615 44,777 1.39
2021-12-03 2021-12-01 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -557 59,226 -0.93 87.68 -48,838 5,192,936
2021-11-23 2021-11-19 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 28,400 28,400
2021-11-23 2021-11-19 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 6,800 59,783 12.83
2020-12-16 2020-12-15 4 ENTA ENANTA PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -5,250 0 -100.00
2020-12-16 2020-12-15 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -1,540 42,248 -3.52 42.52 -65,481 1,796,385
2020-12-16 2020-12-15 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 5,250 43,788 13.62
2020-12-07 2020-12-03 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1,667 13,667 -10.87
2020-12-07 2020-12-03 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1,667 38,538 4.52 30.00 50,010 1,156,140
2020-11-20 2020-11-20 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 30,800 30,800
2020-11-20 2020-11-20 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 7,600 36,871 25.96
2020-08-06 2020-08-05 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1,666 15,334 -9.80
2020-08-06 2020-08-05 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1,666 29,271 6.04 30.00 49,980 878,130
2020-03-16 2020-03-12 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -3,000 17,000 -15.00
2020-03-16 2020-03-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 3,000 27,605 12.19 30.00 90,000 828,150
2020-02-18 2020-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -940 24,605 -3.68 52.76 -49,594 1,298,160
2020-02-18 2020-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 2,475 25,545 10.73
2020-02-18 2020-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 412 23,070 1.82
2020-01-06 2019-12-16 4 ENTA ENANTA PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -5,250 5,250 -50.00
2020-01-06 2019-12-16 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -2,331 22,658 -9.33 63.88 -148,904 1,447,393
2020-01-06 2019-12-16 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 5,250 24,989 26.60
2019-11-25 2019-11-22 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1,592 19,818 -7.44
2019-11-25 2019-11-22 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1,592 19,739 8.77 31.42 50,021 620,199
2019-11-25 2019-06-26 4/A ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 3,295 13,147 33.44 31.42 103,529 413,079
2019-11-18 2019-11-18 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 30,000 30,000
2019-09-30 2019-09-27 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -5,000 20,000 -20.00
2019-09-30 2019-09-27 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 5,000 19,871 33.62 30.00 150,000 596,130
2019-06-26 2019-06-26 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -3,295 21,410 -13.34
2019-06-26 2019-06-26 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 3,295 14,871 28.46 31.42 103,529 467,247
2019-03-07 2019-03-06 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -795 24,705 -3.12
2019-03-07 2019-03-06 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1,724 70,976 -2.37
2019-03-07 2019-03-06 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 795 26,497 3.09 31.42 24,979 832,536
2019-03-07 2019-03-06 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1,724 25,702 7.19 34.70 59,823 891,859
2019-02-13 2019-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
S - Sale X -3,270 23,978 -12.00 95.28 -311,562 2,284,600
2019-02-13 2019-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -4,579 27,248 -14.39 88.88 -406,982 2,421,802
2019-02-13 2019-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 10,000 31,827 45.81
2019-02-13 2019-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 4,000 21,827 22.44
2019-01-24 2019-01-22 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,000 72,700 -2.68
2019-01-24 2019-01-22 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 2,000 17,827 12.64 34.70 69,400 618,597
2018-12-06 2018-12-06 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,000 74,700 -2.61
2018-12-06 2018-12-06 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 2,000 15,827 14.46 34.70 69,400 549,197
2018-11-20 2018-11-16 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 18,000 18,000
2018-10-02 2018-10-01 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1,500 76,700 -1.92
2018-10-02 2018-10-01 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1,500 13,827 12.17 34.70 52,050 479,797
2018-02-13 2018-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -2,065 12,327 -14.35 76.84 -158,685 947,268
2018-02-13 2018-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 4,822 14,392 50.39
2018-02-13 2018-02-12 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 2,000 9,570 26.42
2018-02-12 2018-02-08 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -4,300 78,200 -5.21
2018-02-12 2018-02-08 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
M - Exercise 4,300 7,570 131.50 34.70 149,210 262,679
2017-11-21 2017-11-17 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 21,500 21,500
2017-02-15 2017-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
F - Taxes -830 3,270 -20.24 29.82 -24,746 97,495
2017-02-15 2017-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
A - Award 2,200 4,100 115.79
2016-11-22 2016-11-18 4 ENTA ENANTA PHARMACEUTICALS INC
Restricted Stock Units
A - Award 10,500 10,500
2016-11-22 2016-11-18 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 25,000 25,000
2016-05-12 2016-05-11 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
P - Purchase 500 1,900 35.71 24.44 12,222 46,446
2015-11-24 2015-11-20 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 25,500 25,500
2015-02-17 2015-02-17 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
P - Purchase 400 1,400 40.00 33.10 13,240 46,340
2015-02-17 2015-02-17 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
P - Purchase 600 1,000 150.00 33.47 20,082 33,470
2015-02-17 2015-02-13 4 ENTA ENANTA PHARMACEUTICALS INC
Common Stock
P - Purchase 400 400 33.00 13,200 13,200
2014-11-21 2014-11-20 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 27,500 27,500
2014-05-12 2014-05-09 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 82,500 82,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)